查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590821

基因型鉴定市场：按产品、技术和应用分类 - 2025-2030 年全球预测

Genotyping Market by Product (Instruments & Services, Reagents & Kits), Technology (Capillary Electrophoresis, Mass Spectrometry, Microarray), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年基因型鉴定市值为207.1亿美元，预计到2024年将达到236.3亿美元，复合年增长率为14.14%，到2030年将达到522.9亿美元。

基因型鉴定包括透过检查个体的 DNA 序列来确定基因组成差异的过程。这对于个人化医疗、药物基因组学、生物技术和农业生物学等多种应用至关重要。对精准医疗日益增长的需求推动了基因型鉴定的需求，精准医疗根据个人的基因组成提供量身定制的医疗保健解决方案。在农业中，它有助于制定提高产量和抗病能力的作物改良计划。 KEYWORD市场价值链从生物医学研究中心和医院延伸到农业机构和生物技术公司。市场成长主要是由于基因组技术的进步、DNA定序成本的下降以及遗传疾病数量的增加推动了早期诊断和介入的需求。此外，人们对降低医疗保健成本的日益关注正在推动疾病预防和控制的基因型鉴定解决方案的发展。然而，诸如对遗传资料隐私的伦理担忧以及先进基因型鉴定技术的高成本等挑战减缓了市场渗透率。一个主要的成长机会在于整合人工智慧进行实质资料解释，这可以显着提高医疗保健领域的诊断准确性和预测模型。投资便携式且负担得起的基因型鉴定套件，特别是对于低收入地区，代表着巨大的业务成长潜力。此外，高科技公司和学术研究中心之间的合作可以带来增强即时基因型鉴定能力的创新解决方案。然而，监管障碍和遵守严格的遗传资讯法仍然是必须解决的障碍。促进基因组资料的开放获取，同时确保强有力的隐私措施，可以为研究和开发开闢新的途径。因此，彻底解决监管和伦理问题以及技术创新可以将基因型鉴定市场推向更高的高度，并满足不断增长的社会和工业需求。

主要市场统计
基准年[2023] 207.1亿美元
预测年份 [2024] 236.3亿美元
预测年份 [2030] 522.9亿美元
复合年增长率（%） 14.14%

市场动态：揭示快速发展的基因型鉴定市场的关键市场洞察

供需的动态交互作用正在改变基因型鉴定市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 基因型鉴定在药物发现和药物开发中的重要性日益增加
    • 帕金森氏症和透纳氏症遗传疾病的盛行率增加
    • 资料分析中生物资讯解决方案的潜在需求
  • 市场限制因素
    • 相对昂贵的设备
  • 市场机会
    • 定序计划在世界各地的重要性日益增加
    • 农业领域的持续需求
  • 市场挑战
    • 缺乏训练有素的专业人员以及对基因型鉴定资料管理的担忧

波特五力：驾驭基因型鉴定市场的策略工具

波特的五力架构是了解基因型鉴定市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因型鉴定市场的外部影响

外部宏观环境因素在塑造基因型鉴定市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因型鉴定市场的竞争格局

对基因型鉴定市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因型鉴定市场供应商绩效评估

FPNV 定位矩阵是评估基因型鉴定市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製基因型鉴定市场的成功之路

基因型鉴定市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 基因型鉴定在药物发现与开发中日益重要
      • 帕金森氏症和透纳氏症遗传性疾病的增加
      • 资料分析中生物资讯解决方案的潜在需求
    • 抑制因素
      • 相对昂贵的设备
    • 机会
      • 全球定序计划的重要性日益增加
      • 农业产业持续需求
    • 任务
      • 缺乏训练有素的专业人员以及对基因型鉴定资料管理的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章基因型鉴定市场：副产品

  • 设备和服务
  • 试剂和套件

第七章基因型鉴定市场：依技术分类

  • 毛细管电泳
  • 质谱分析
  • 微阵列
  • PCR
  • 定序

第八章基因型鉴定市场：依应用分类

  • 诊断
  • 药物发现

第 9 章美洲基因型鉴定市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太基因基因型鉴定市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的基因型鉴定市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agena Bioscience, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Biofortuna Limited
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Precision Biomarker Resources, Inc.
  • Qiagen NV
  • Roche Diagnostics Corporation
  • Sigma-Aldrich Corporation
  • ThermoFisher Scientific, Inc.
Product Code: MRR-A77F2EE7AB77

The Genotyping Market was valued at USD 20.71 billion in 2023, expected to reach USD 23.63 billion in 2024, and is projected to grow at a CAGR of 14.14%, to USD 52.29 billion by 2030.

Genotyping encompasses the process of determining differences in the genetic makeup by examining the individual's DNA sequence. It is crucial for various applications such as personalized medicine, pharmacogenomics, biotechnology, and agricultural biology. The necessity of genotyping stems from the increasing demand for precision medicine which caters to tailored healthcare solutions based on individual genetic makeups. In the agricultural sector, it helps devise crop improvement programs to enhance yield and disease resistance. The value chain of genotyping market extends from biomedical research centers and hospitals to agricultural institutes and biotechnology companies. Market growth is influenced significantly by advancements in genomic technologies, decreasing costs of DNA sequencing, and an increase in genetic diseases spurring demand for early diagnosis and intervention. Additionally, the growing focus on reducing healthcare costs fuels genotyping solutions in disease prevention and management. However, challenges such as ethical concerns regarding genetic data privacy and the high cost of advanced genotyping technologies slow down market penetration. Key growth opportunities exist in the areas of integrating artificial intelligence for substantial data interpretation, which can greatly enhance diagnostic accuracy and prediction models in healthcare. Investment in portable and affordable genotyping kits, especially for low-income regions, presents significant business growth potential. Moreover, collaborations between tech companies and academic research centers can yield innovative solutions enhancing real-time genotyping capabilities. Nevertheless, regulatory hurdles and compliance with stringent genetic information laws remain deterrents that need addressing. Fostering open access to genomic data while ensuring robust privacy measures could unlock new avenues of research and development. Therefore, a thorough approach towards resolving regulatory and ethical concerns along with technological innovation can propel the genotyping market to significant heights, aligning it with growing societal and industry-specific demands.

KEY MARKET STATISTICS
Base Year [2023] USD 20.71 billion
Estimated Year [2024] USD 23.63 billion
Forecast Year [2030] USD 52.29 billion
CAGR (%) 14.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genotyping Market

The Genotyping Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing significance of genotyping in drug discovery and development
    • Growing prevalence of genetic diseases such as Parkinson's, turner syndrome
    • Potential demand for bioinformatics solutions in data analysis
  • Market Restraints
    • Relatively expensive equipment
  • Market Opportunities
    • Emerging importance of sequencing projects globally
    • Ongoing demand in agriculture industries
  • Market Challenges
    • Lack of trained professional and concerns in data management in genotyping

Porter's Five Forces: A Strategic Tool for Navigating the Genotyping Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genotyping Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genotyping Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genotyping Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genotyping Market

A detailed market share analysis in the Genotyping Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genotyping Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genotyping Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genotyping Market

A strategic analysis of the Genotyping Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Biofortuna Limited, Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., Precision Biomarker Resources, Inc., Qiagen NV, Roche Diagnostics Corporation, Sigma-Aldrich Corporation, and ThermoFisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Genotyping Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments & Services and Reagents & Kits.
  • Based on Technology, market is studied across Capillary Electrophoresis, Mass Spectrometry, Microarray, PCR, and Sequencing.
  • Based on Application, market is studied across Diagnostics and Drug Discovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing significance of genotyping in drug discovery and development
      • 5.1.1.2. Growing prevalence of genetic diseases such as Parkinson's, turner syndrome
      • 5.1.1.3. Potential demand for bioinformatics solutions in data analysis
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively expensive equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging importance of sequencing projects globally
      • 5.1.3.2. Ongoing demand in agriculture industries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained professional and concerns in data management in genotyping
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genotyping Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments & Services
  • 6.3. Reagents & Kits

7. Genotyping Market, by Technology

  • 7.1. Introduction
  • 7.2. Capillary Electrophoresis
  • 7.3. Mass Spectrometry
  • 7.4. Microarray
  • 7.5. PCR
  • 7.6. Sequencing

8. Genotyping Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery

9. Americas Genotyping Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Genotyping Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Genotyping Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agena Bioscience, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories Inc.
  • 4. Biofortuna Limited
  • 5. Danaher Corporation
  • 6. Eurofins Scientific SE
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Illumina, Inc.
  • 9. Merck KGaA
  • 10. PerkinElmer, Inc.
  • 11. Precision Biomarker Resources, Inc.
  • 12. Qiagen NV
  • 13. Roche Diagnostics Corporation
  • 14. Sigma-Aldrich Corporation
  • 15. ThermoFisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GENOTYPING MARKET RESEARCH PROCESS
  • FIGURE 2. GENOTYPING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOTYPING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOTYPING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOTYPING MARKET SIZE, BY INSTRUMENTS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOTYPING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOTYPING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOTYPING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOTYPING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2023